• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期恶性黑色素瘤患者管理中体外化学敏感性集落形成(干细胞)试验的经验。

Experience with the colony-forming (stem cell) assay of in vitro chemosensitivity in the management of patients with advanced malignant melanoma.

作者信息

MacKie R M, Gaukroger J M, Wilson L, Gold J

出版信息

Cancer Treat Rep. 1984 Sep;68(9):1185-8.

PMID:6478453
Abstract

Twenty-two patients with advanced malignant melanoma had tumor nodules biopsied and tumor cell colonies established in vitro in the colony-forming assay in the presence of vindesine. The patients then received iv vindesine at a dose of 3 mg/m2/week for 6 weeks. In four patients, in vitro death of cells exposed to vindesine in vitro correlated with clinical response to therapy. In the remaining 18 patients, lack of both in vitro and clinical response was noted.

摘要

22例晚期恶性黑色素瘤患者的肿瘤结节进行了活检,并在长春地辛存在的情况下,通过集落形成试验在体外建立了肿瘤细胞集落。然后患者接受静脉注射长春地辛,剂量为3mg/m²/周,共6周。4例患者中,体外暴露于长春地辛的细胞死亡与临床治疗反应相关。在其余18例患者中,观察到体外和临床均无反应。

相似文献

1
Experience with the colony-forming (stem cell) assay of in vitro chemosensitivity in the management of patients with advanced malignant melanoma.晚期恶性黑色素瘤患者管理中体外化学敏感性集落形成(干细胞)试验的经验。
Cancer Treat Rep. 1984 Sep;68(9):1185-8.
2
The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.
Clin Oncol. 1981 Mar;7(1):33-7.
3
Dexamethasone, medroxyprogesterone acetate, and vindesine modulation of human malignant melanoma growth in soft agar.地塞米松、醋酸甲羟孕酮和长春地辛对人恶性黑色素瘤在软琼脂中生长的调节作用
Anticancer Res. 1985 Mar-Apr;5(2):189-92.
4
Vindesine for metastatic malignant melanoma. A phase II trial.长春地辛治疗转移性恶性黑色素瘤。一项II期试验。
Am J Clin Oncol. 1983 Oct;6(5):561-4.
5
Broad phase II study of vindesine.
Cancer Treat Rep. 1981 Sep-Oct;65(9-10):877-9.
6
New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.卵巢癌和恶性黑色素瘤的新药:采用人肿瘤干细胞检测法进行体外II期筛选
Cancer Treat Rep. 1981 Jan-Feb;65(1-2):1-12.
7
Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
Cancer Treat Rep. 1984 Sep;68(9):1199-200.
8
Phase II trial of vindesine in patients with malignant melanoma.
Cancer Treat Rep. 1980 Jan;64(1):179-81.
9
Phase II study of vindesine in metastatic malignant melanoma.
Cancer Treat Rep. 1981 Mar-Apr;65(3-4):355-6.
10
[Pilot study with vindesine as monotherapy in metastatic malignant melanomas].
MMW Munch Med Wochenschr. 1983 Jan 21;125(3):54-6.

引用本文的文献

1
Predictive chemosensitivity testing in malignant melanoma: reliable methodology--ineffective drugs.恶性黑色素瘤的预测性化学敏感性测试:可靠的方法——无效药物
Br J Cancer. 1988 Dec;58(6):734-7. doi: 10.1038/bjc.1988.299.
2
Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development.人类肿瘤克隆分析:在临床肿瘤学和新型抗肿瘤药物研发中的应用
Cancer Metastasis Rev. 1988 Dec;7(4):357-71. doi: 10.1007/BF00051376.